BUPRENORPHINE
Total Payments
$323,265
Transactions
21
Doctors
6
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $48,876 | 5 | 0 |
| 2020 | $40,565 | 6 | 1 |
| 2019 | $90,244 | 3 | 0 |
| 2018 | $138,975 | 2 | 0 |
| 2017 | $4,605 | 5 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $318,660 | 16 | 98.6% |
| Consulting Fee | $4,283 | 1 | 1.3% |
| Food and Beverage | $322.00 | 4 | 0.1% |
Payments by Type
Research
$318,660
16 transactions
General
$4,605
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multi Center Study to Evaluate the Skin Irritation and Sensitization Potential of a Vehicle Patch for Buprenorphine Transdermal System Amneal Pharmaceuticals 11749706 | Amneal Pharmaceuticals LLC | $138,975 | 0 |
| BPMG BTOD REMS Program | Teva Pharmaceuticals USA, Inc. | $90,244 | 0 |
| BTOD REMS Program | Teva Pharmaceuticals USA, Inc. | $89,441 | 1 |
Top Doctors Receiving Payments for BUPRENORPHINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $318,499 | 13 |
| , MD | Pulmonary Disease | Chapel Hill, NC | $4,283 | 1 |
| , M.D | Addiction Psychiatry | Baltimore, MD | $161.40 | 3 |
| , MD | Pediatrics | Salt Lake City, UT | $80.50 | 1 |
| , MD | Neonatal-Perinatal Medicine | Philadelphia, PA | $80.50 | 1 |
| , M.D | Neonatal-Perinatal Medicine | Chicago, IL | $80.50 | 1 |
| , MD | Neonatal-Perinatal Medicine | Miami, FL | $80.50 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $179,685
- Amneal Pharmaceuticals LLC $138,975
- Chiesi USA, Inc. $4,605
Product Information
- Type Drug
- Total Payments $323,265
- Total Doctors 6
- Transactions 21
About BUPRENORPHINE
BUPRENORPHINE is a drug associated with $323,265 in payments to 6 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2021. In 2021, $48,876 was paid across 5 transactions to 0 doctors.
The most common payment nature for BUPRENORPHINE is "Unspecified" ($318,660, 98.6% of total).
BUPRENORPHINE is associated with 3 research studies, including "A Multi Center Study to Evaluate the Skin Irritation and Sensitization Potential of a Vehicle Patch for Buprenorphine Transdermal System Amneal Pharmaceuticals 11749706" ($138,975).